Author's posts
Big Pharma Boosts Drug Prices As Supplies Run Low, Study Reveals
Drug companies display “opportunistic behavior” while pricing products that are in short supply, the authors of a new study allege.
Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy
Several companies working in the burgeoning field of immuno-oncology have staged IPOs this year, and at least two more are on the way. But will enthusiastic investors be patient enough to see a payoff?
Paying People To Lower Their Cholesterol Works But Is It Cost-Effective?
Offering financial rewards to patients who lower their bad cholesterol by adhering to statin regimens could help prevent heart disease, but there are lingering questions about whether such a strategy is worth the added healthcare costs.
BI Joins Pharma Frenzy For Cancer-Killing Viruses With $244M Acquisition
With its purchase of ViraTherapeutics, German’s Boehringer Ingelheim joins a large and growing list of Big Pharma companies investing in viruses that are engineered to seek out and destroy cancer.
Will Trump’s Pharma Shaming Bring Down Drug Prices? Not Likely, Poll Says
President Trump promised “voluntary massive drops in prices” from Big Pharma. Americans are skeptical.
Insurers Fret Over How To Pay For Gene Therapy As The Science Advances
Most health care payers are worried about gene therapy treatments that will cost hundreds of thousands of dollars, which is why most are looking into alternative payment plans to cover the new technology.
You May Start Seeing Drug Prices In Ads, But Will You Understand The Point?
The newly passed Senate amendment requiring drug companies to disclose the prices of their products in direct-to-consumer advertising is raising a lot of questions.
Study Shows How Vaccine Discourse Is Twisted By Russian Twitter Trolls
The Internet Research Agency, the Russian group indicted by a federal grand jury earlier this year for charges related to meddling in the 2016 elections, has also spread misinformation about vaccines on Twitter, new research reveals.
How A Supercomputer Named Dr. Crusher Perfected Cancer Treatments For 21 Patients
A newly published study suggests that artificial intelligence can be used to select cancer treatments for individual patients based on their DNA and RNA profiles, but several obstacles must be overcome before the technology can be widely implemented.
Opioid Use Hasn’t Declined In The Last Decade Despite Addiction Crisis
An addiction epidemic has been acknowledged. A public health emergency was declared. But opioid addiction rates show no signs of slowing, new research reveals.
- 1
- 2
